United States of America
Dr. Rakhilin has extensive experience in drug discovery and developmental processes. Prior to PharmaIN, Dr. Rakhilin was Chief Scientific Officer at IBC Generium in Russia, a bio-therapeutic company, and Principal Scientist at Biogen Idec as well as Head of a drug discovery group at Novartis. Dr. Rakhilin received an MS and PhD in Biochemistry from Lomonosov Moscow State University with a post-doctoral fellowship at the University of Chicago and at Rockefeller University. He is the author of multiple publications and patents.